Navigation Links
BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
Date:9/3/2013

JERUSALEM, Sept. 3, 2013 /PRNewswire/ -- BioLineRx (NASDAQ: BLRX; TASE: BLRX), a biopharmaceutical development company, announced today that an Issue Notification has been received from the United States Patent and Trademark Office (USPTO) for US Patent  No. 8,455,450, which claims the use of BL-8040's composition for obtaining hematopoietic precursor cells (e.g. stem cells) for use in bone marrow transplantation. The issued patent has a term extending to November 2029. This patent is part of BL-8040's expanding patent portfolio, which includes an additional six issued patents on the composition of matter and 29 patent applications on new indications, granted or pending worldwide, providing a strong intellectual property estate around BL-8040.

(Logo: http://photos.prnewswire.com/prnh/20130730/630769 )

"We are pleased that the USPTO has issued this patent for a method of obtaining stem cells by administering BL-8040, which further strengthens the patent position we have for this promising compound," stated Dr. Kinneret Savitsky, Chief Executive Officer of BioLineRx. "BL-8040 is currently undergoing a Phase 2 trial for the treatment of acute myeloid leukemia, partial results of which are expected towards the end of this year. Robust patent protection provides the foundation to pursue multiple additional oncological and hematological indications," concluded Dr. Savitsky.

About BL-8040
BL-8040 is a clinical-stage drug candidate for the treatment of acute myeloid leukemia, as well as other types of hematological cancer
'/>"/>

SOURCE BioLineRx
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioLineRx to Present at 15th International Celiac Disease Symposium
2. BioLineRx to Present at 2013 Stifel Nicolaus Healthcare Conference In Boston
3. BioLineRx Appoints B. J. Bormann to Board of Directors
4. BioLineRx Reports Second Quarter 2013 Results
5. BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 in Treatment of Thrombocytopenia
6. Halozyme Announces Roche Receives Marketing Authorization for Herceptin SC in European Union
7. Neurotrope, Inc., Announces Reverse Merger and Completion of $21.9 Million Private Offering
8. Rotech Announces Confirmation of Plan of Reorganization
9. Upsher-Smith Announces Commercial Availability Of Morphine Sulfate ER Capsules
10. Neurocrine Biosciences Announces the Start of Second Phase III Study of Elagolix in Endometriosis
11. Eisai Inc. Announces Non-Exclusive Licensing Agreement with Generic Drug Manufacturer to Provide Generic Version of donepezil HCl 23 mg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015 Electrophysiologist ... Institute recently traveled to Boston, MA ... at the 2015 Heart Rhythm Society conference. These ... to focus on the ideas, people and technology ... Convergent is a hybrid, minimally invasive cardiac operation ...
(Date:5/22/2015)... Texas , May 22, 2015 ... million in 2014 and is estimated to reach $90.7 million ... 2019. Browse through the TOC of North America ... segments, with the help of various tables and figures. ... receive 10% customization on this report.   ...
(Date:5/22/2015)... YORK , May 22, 2015  The ... of Zarxio (filgrastim-sndz) -- the first biosimilar product ... -- points toward growth in the contract ... The mainstream CMO industry is geared to the ... to produce major biopharmaceutical products. The healthcare market ...
Breaking Medicine Technology:St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 2North America Dental Lasers Market is Expected to Reach $90.7 Million by 2019, at a CAGR of 9.2% From 2014 to 2019 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... of ORMD 0801, Oral Insulin Capsule, ... on Type 1 Diabetics, ... a developer,of oral delivery systems, announced today that it has commenced Phase ... at the,Hadassah University Medical Center in Jerusalem, Israel., Oramed,s Phase 2A ...
... Cancer Research Aims to Raise Awareness about,the Importance of Clinical Trial Participation, ... with cancer would be receptive to participating in ... In a survey of 6,000 cancer patients, 85 percent were either unaware ... in a clinical trial was an option. ...
Cached Medicine Technology:Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics 2Video: The Looming Crisis in Cancer Drug Development: 97% of Adult Cancer Patients Do Not Take Advantage of Clinical Trial Programs 2Video: The Looming Crisis in Cancer Drug Development: 97% of Adult Cancer Patients Do Not Take Advantage of Clinical Trial Programs 3
(Date:5/24/2015)... For people who are keen on the Enterokinase ... Research Report would be an useful report to refer ... present market scenario of this industry. The report also ... of this industry. The report summarizes key statistics of ... in this industry. The report is a valuable source ...
(Date:5/24/2015)... ProPin is a set of self-animating ... Utilize ProPin to pin point locations on a map, to ... , ProPin allows users to choose from 30 simplistic presets with ... on-screen controls, video editors can easily manipulate ProPin presets as a ... with absolute ease. , Using ProPin is easy, simply drag a ...
(Date:5/23/2015)... 23, 2015 On Saturday, May 23, 2015, ... playground for Branches Florida City exactly five years to the ... in 2010. , A large fire tore through the Branches ... 23, 2010 in the middle of the night as neighbors, ... later declared arson even though it is suspected that the ...
(Date:5/23/2015)... 23, 2015 On May 16, the team ... event was a 5k mud obstacle run that raised funds ... million people worldwide, and the reason we participated was to ... Davis, owner of Farrell’s eXtreme Bodyshaping. “One-hundred percent of the ... , The event was not only attended by eXtreme Bodyshaping ...
(Date:5/23/2015)... Injury lawyer Steven H. Heisler commented today ... the Maryland legislature but which has not been signed to ... HB 449 with overwhelming bipartisan support on April ... into law. This bill ensures that fracking is prohibited in ... the danger of fracking to our water supplies and the ...
Breaking Medicine News(10 mins):Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Five Years After Fire, Branches Rebuilds Playground 2Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 3
... Increase ... Total Debt Reduced, BIRMINGHAM, Ala., ... reported its results of,operations for the fourth quarter ended December 31, ... the Company,s inpatient,rehabilitation hospitals increased by 4.6% and discharges increased by,0.9%., ...
... 25 Lung Cancer Alliance,(LCA) cautioned today that recently ... more people each year than all the other,major cancers ... of government statistics,entitled Cancer Facts and Figures for 2008, ... been made against cancer over the,past 15 years.", ...
... - 2007 INVESTMENTS TOTAL $1.1 BILLION ... 7.3% ... - NORMALIZED ANNUAL FFO PER SHARE UP ... today announced its fourth quarter and,full year 2007 operating results and investment activity., "We ...
... role of two proteins that contribute to disease-causing bacteria ... The finding is a step toward development of drug ... source. Before researchers can design such drugs, they must ... conflict between bacteria and the agents that kill them. ...
... Senior Living,Inc. (NYSE: SRZ ) will release ... 3, 2008. Management will not be hosting a,conference ... of,variances will be included in the Company,s press ... before markets open., About Sunrise Senior Living, ...
... Slammed as Unconstitutional, Springs, Wife Previously Filed State Malpractice Lawsuit ... ... Feb. 25 A lawsuit filed today in U.S. District,Court for the ... Ron Springs as one of the eleven plaintiffs,challenging the constitutionality of the ...
Cached Medicine News:Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 2Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 3Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 4Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 5Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 6Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 7Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 8Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 9Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 10Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 11Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 12Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 13Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 14Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 15Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 16Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 17Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 18Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 19Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 20Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 21Health News:HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007 22Health News:'Enormous Progress' in Reducing Cancer Does Not Include Lung Cancer 2Health News:NHP Reports Fourth Quarter and Full Year 2007 Earnings 2Health News:NHP Reports Fourth Quarter and Full Year 2007 Earnings 3Health News:NHP Reports Fourth Quarter and Full Year 2007 Earnings 4Health News:NHP Reports Fourth Quarter and Full Year 2007 Earnings 5Health News:NHP Reports Fourth Quarter and Full Year 2007 Earnings 6Health News:NHP Reports Fourth Quarter and Full Year 2007 Earnings 7Health News:NHP Reports Fourth Quarter and Full Year 2007 Earnings 8Health News:NHP Reports Fourth Quarter and Full Year 2007 Earnings 9Health News:NHP Reports Fourth Quarter and Full Year 2007 Earnings 10Health News:NHP Reports Fourth Quarter and Full Year 2007 Earnings 11Health News:NHP Reports Fourth Quarter and Full Year 2007 Earnings 12Health News:NHP Reports Fourth Quarter and Full Year 2007 Earnings 13Health News:Scientists identify proteins that help bacteria put up a fight 2
... FoamWrap Final Flexion Wraps restore full ... injury or when lost due to arthritic ... breathable, foam-lined material hugs the finger to ... to restore motion. One size. Sold in ...
One splint does it all....
... the physiological causes of minor knee pain ... works in concert with the motion of ... liner and patellar tendon and assisting in ... Semi-rigid plastic support with high density foam ...
... post-operative knee braces are designed to provide ... ,Adjustable and versatile, ROM braces are ... care professionals. The braces are extremely patient-friendly, ... dial combination hinges that allow you to ...
Medicine Products: